These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 10384859)

  • 41. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.
    Hrdý I; Cammack R; Stopka P; Kulda J; Tachezy J
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5033-6. PubMed ID: 16304169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
    Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
    Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacokinetics of one single preoperative dose of metronidazole or tinidazole.
    Solhaug JH; Bergan T; Leinebø O; Rosseland AR; Spada L; Vaagenes F
    Scand J Gastroenterol Suppl; 1984; 90():89-96. PubMed ID: 6588485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative pharmacokinetic studies of ornidazole and metronidazole in man.
    Schwartz DE; Jeunet F
    Chemotherapy; 1976; 22(1):19-29. PubMed ID: 1253627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.
    Lindmark DG; Müller M
    Antimicrob Agents Chemother; 1976 Sep; 10(3):476-82. PubMed ID: 791102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current clinical applications and dose regimens of metronidazole and related nitroimidazoles.
    McLean AJ; Ioannides-Demos LL; Spicer WJ
    Med J Aust; 1984 Aug; 141(3):163-6. PubMed ID: 6749031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
    Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit.
    Fish DN
    Int J Antimicrob Agents; 2007 Jun; 29(6):715-23. PubMed ID: 17433631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
    Slavik RS; Jewesson PJ
    Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice.
    Tan SY; Kan E; Lim WY; Chay G; Law JH; Soo GW; Bukhari NI; Segarra I
    J Pharm Pharmacol; 2011 Jul; 63(7):918-25. PubMed ID: 21635257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical pharmacokinetics of teicoplanin.
    Rowland M
    Clin Pharmacokinet; 1990 Mar; 18(3):184-209. PubMed ID: 2138946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study.
    Pellegrini M; Urso R; Giorgi G; Bayeli PF; Marzocca G; Cerretani D
    Aliment Pharmacol Ther; 2005 Aug; 22(4):343-8. PubMed ID: 16098001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antibacterial and bactericidal activity of tinidazole against anaerobic bacteria comparing with metronidazole (author's transl)].
    Ninomiya K; Kobata S; Imamura H; Mochizuki I; Watanabe K
    Jpn J Antibiot; 1976 Mar; 29(3):325-31. PubMed ID: 1271586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metronidazole elimination is preserved in the elderly.
    Loft S; Egsmose C; Sonne J; Poulsen HE; Døssing M; Andreasen PB
    Hum Exp Toxicol; 1990 May; 9(3):155-9. PubMed ID: 2375881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of intravenous metronidazole at different dosages in healthy subjects.
    Lau AH; Emmons K; Seligsohn R
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):386-90. PubMed ID: 1748538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms.
    Dingsdag SA; Hunter N
    J Antimicrob Chemother; 2018 Feb; 73(2):265-279. PubMed ID: 29077920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.